Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Inogen, Inc (INGN : NSDQ)

• Company Description    Inogen Inc. develops, manufactures and markets POC. POCs are used by patients who suffer from chronic respiratory conditions and need long-term oxygen therapy. POCs concentrate the air around the patient, filter out the nitrogen and other unwanted substances and deliver oxygen. The company provides oxygen concentrator solutions for portable and stationary use. Inogen's flagship product, One G4 is a single-solution POC. Number of Employees: 766

• Price / Volume Information    Yesterday's Closing Price: $8.54 Daily Weekly Monthly 20 Day Moving Average: 181,729 shares Shares Outstanding: 27.04 (millions) Market Capitalization: $230.93 (millions) Beta: 1.78 52 Week High: $12.91 52 Week Low: $5.70 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 14.48% 12.14% 12 Week 28.61% 16.57% Year To Date -6.87% -16.81%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 859 WARD DRIVE - GOLETA,CA 93111 USA ph: 805-562-0500 fax: - ir@inogen.net http://www.inogen.com

• General Corporate Information    Officers Kevin R. M. Smith - Chief Executive Officer and President Elizabeth Mora - Chairperson of the Board Michael Bourque - Chief Financial Officer Glenn Boehnlein - Director Kevin King - Director Peer Information Inogen, Inc (ABMD) Inogen, Inc (DMDS) Inogen, Inc (CPWY.) Inogen, Inc (EQUR) Inogen, Inc (ECIA) Inogen, Inc (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 45780L104 SIC: 3842 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/25 Next Expected EPS Date: 11/06/25 Share - Related Items Shares Outstanding: 27.04 Most Recent Split Date: (:1) Beta: 1.78 Market Capitalization: $230.93 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.24 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.94 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/06/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 1.15 Price/Cash Flow: - Price / Sales: 0.67 EPS Growth vs. Year Ago Period: 37.50% vs. Previous Quarter: 40.00% Sales Growth vs. Year Ago Period: 3.96% vs. Previous Quarter: 12.15% ROE 06/30/25 - -13.77 03/31/25 - -14.76 12/31/24 - -19.43 ROA 06/30/25 - -8.52 03/31/25 - -9.01 12/31/24 - -11.70 Current Ratio 06/30/25 - 3.03 03/31/25 - 3.07 12/31/24 - 2.42 Quick Ratio 06/30/25 - 2.67 03/31/25 - 2.67 12/31/24 - 2.09 Operating Margin 06/30/25 - -7.58 03/31/25 - -8.08 12/31/24 - -10.69 Net Margin 06/30/25 - -7.58 03/31/25 - -8.08 12/31/24 - -10.69 Pre-Tax Margin 06/30/25 - -7.78 03/31/25 - -8.24 12/31/24 - -10.86 Book Value 06/30/25 - 7.42 03/31/25 - 7.36 12/31/24 - 7.30 Inventory Turnover 06/30/25 - 7.62 03/31/25 - 7.44 12/31/24 - 7.48 Debt-to-Equity 06/30/25 - 0.00 03/31/25 - 0.00 12/31/24 - 0.00 Debt-to-Capital 06/30/25 - 0.00 03/31/25 - 0.00 12/31/24 - 0.00

Powered by Zacks Investment Research ©